-

Mount Sinai Installs Visium Fixtures Using State of the Art Far-UVC Technology in New Clinic

Far-UVC adds a layer of protection for patients with long COVID and other complex, chronic illnesses

NEW YORK--(BUSINESS WIRE)--Lit Thinking, a premier Far-UVC technology company, is excited to announce Mount Sinai has installed ten Visium fixtures in their newly constructed, state-of-the-art Cohen Center for Recovery from Complex Chronic Illnesses (CoRE). Visium is a UL-certified Far-UVC fixture that continuously inactivates airborne pathogens using the transformative power of human-safe Far-UVC energy. Academic studies have shown that Far-UVC can inactivate bacteria, viruses, and molds with sufficient exposure, making it a groundbreaking tool for any indoor space to use 24/7 to safely sanitize air and surfaces in a sustainable, energy-efficient manner.

The CoRE facility, located at The Mount Sinai Hospital on the Upper East Side of Manhattan, is dedicated to serving the long COVID community and will be equipped to handle up to 700 new patients a year with infection-associated complex conditions. In the US alone, long COVID is conservatively estimated to affect more than 17 million individuals. Senator Bernie Sanders introduced the Long COVID Research Moonshot Act of 2024, which aims to fund research, develop treatments, and enhance care, particularly for underserved communities. This legislation is crucial as it acknowledges long COVID as a public health emergency, providing much-needed resources and attention to millions whose quality of life and ability to work are severely impacted. This clinic aims to be a model for future facilities to address the unique needs of patients who are often suffering from debilitating, unexplained and unaddressed symptoms related to long COVID, long Lyme Disease, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Ehlers-Danlos syndrome.

Patients with long-term chronic illnesses are often at heightened risk of acquiring infections so the need for healthcare facilities to take enhanced precautions with infection prevention systems is paramount. As part of a multi-layered approach to mitigate the risk of exposure, the CoRE facility will rely on protocols including masking, rapid PCR testing, HEPA-filtration and state-of-the-art Visium fixtures to rapidly inactivate any potential airborne pathogens. The ten recessed mount Visium fixtures are installed in the ceiling throughout the facility to ensure thorough coverage in every area where patients and staff interact.

What makes Visium a unique pathogen fighting system is that it is virtually invisible, silent and highly effective, and operates on only 14W of energy per device which aligns with New York City’s decarbonization initiatives required by Local Law 97 as well as the Joint Commission’s voluntary Sustainable Healthcare Certification program.

“Our work with the CoRE center emphasizes our commitment to advancing healthcare through innovation, collaboration and sustainable technology,” said John Rajchert, CEO of Lit Thinking. “By integrating Visium Far-UVC technology, Mount Sinai is not only leading the way in infection prevention but also setting a new standard for healthcare facilities nationwide."

Mount Sinai's installation of Visium fixtures at the CoRE Center reflects a shared commitment to providing a safer environment for patients with complex chronic illnesses, ensuring that they receive the care they need in a protected setting. As healthcare continues to evolve, innovations like Visium will play a pivotal role in shaping safer, more resilient environments for patients and staff alike. Lit Thinking is honored to be part of this transformative journey, dedicated to enhancing patient outcomes through cutting-edge technology and sustainable solutions.

About Lit Thinking

Founded in 2022, Lit Thinking is a private technology firm dedicated to making indoor environments healthier and safer. With expertise in building technology and science, Lit Thinking harnesses the power of human-safe, Far-UVC technology to mitigate airborne pathogen risks effectively. Their state-of-the-art research, proprietary software, and innovative use of Far-UVC light empower businesses and individuals to create safer, healthier, and more productive indoor spaces.

Contacts

Christina Flores
Director, Marketing & Communications
Lit Thinking
christina.flores@litthinking.com
321-299-0096

Lit Thinking


Release Versions

Contacts

Christina Flores
Director, Marketing & Communications
Lit Thinking
christina.flores@litthinking.com
321-299-0096

More News From Lit Thinking

Visium’s Installation at Pig Hill Farms: A New Era in Biosecurity with Far-UVC Technology

ALVORD, Iowa--(BUSINESS WIRE)--VISIUM’s innovative Far-UVC sanitization technology is installed at Pig Hill Farms, marking a significant advancement in the fight against diseases, such as Porcine Reproductive and Respiratory Syndrome (PRRS). This installation demonstrates Far-UVC’s diverse applications across industries, as it offers effective broad spectrum biosecurity measures for the livestock industry. PRRS and other disease threats represent ongoing challenges in the swine industry. PRRS a...

VISIUM Announces Installation of Visium Devices at Miami Dolphins Training Facility in Clean Air Advancement

ORLANDO, Fla.--(BUSINESS WIRE)--VISIUM today announced the installation of its Visium Far-UVC sanitization technology at the Miami Dolphins training facility, the Baptist Health Training Complex, ushering in a new era of protection to further improve athlete health and performance. This partnership demonstrates VISIUM’s innovative application in professional sports, offering an added layer of biosecurity to support player health, recovery, and availability. Visium technology uses a specific wav...

VISIUM, Formerly Lit Thinking, Opens ‘Visium UltraLabs’ Research Facility to Pioneer Next-Generation Infection Prevention Technology

WEST PALM BEACH, Fla.--(BUSINESS WIRE)--VISIUM, a leading innovator in Far-UVC technology, today announced its official rebrand from Lit Thinking and the grand opening of its new 5,000 sq. ft. research laboratory at Cornell Tech Park, VISIUM UltraLabs. The new facility will serve as the central hub for the company’s ambitious research program, which aims to achieve critical breakthroughs in the development of Ultra Wide Band Gap semiconductors, as well as produce the world’s first commercially...
Back to Newsroom